Results 121 to 130 of about 42,255 (232)

Restenosis risk factors after coronary stenting in metabolic syndrome patients

Кардиоваскулярная терапия и профилактика, 2007
This review is devoted to coronary restenosis after stent implantation in metabolic syndrome (MS) patients. It is known that some clinical factors increase restenosis risk, first of all, diabetes mellitus.
N. M. Danilov, T. T. Gorgadze, A. P. Savchenko, I. E. Chazova   +3 more
doaj  

Comparative efficacy of drug-eluting balloon and drug-eluting stent for treatment of in-stent restenosis: a systematic review and meta-analysis

Journal of the Pakistan Medical Association
Objective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest ...
Tinanda Tarigan, Daniel Sukmadja, Kaka Citta Prasiddha, Rizkan Triatmaja   +3 more
doaj   +1 more source

Assessment of Plaque Characteristics by Contrast-Enhanced Ultrasound and Stent Restenosis following Carotid Artery Stenting: A Retrospective Study

Medicina
Background and objective: carotid artery stenosis contributes significantly to ischemic strokes, with management options including carotid endarterectomy (CEA) and carotid artery stenting (CAS) ischemic stroke risk can be reduced.
Agnė Gimžauskaitė, Donatas Inčiūra, Gintautė Diringytė, Saulius Lukoševičius, Rytis Kaupas, Andrius Pranculis, Aistė Mačiulaitytė, Algidas Basevičius, Milda Kuprytė, Edgaras Stankevičius, Jurgita Plisienė   +10 more
doaj   +1 more source

Current Management of In-Stent Restenosis

Journal of Clinical Medicine
In-stent restenosis (ISR) remains the primary cause of target lesion failure following percutaneous coronary intervention (PCI), resulting in 10-year incidences of target lesion revascularization at a rate of approximately 20%. The treatment of ISR is challenging due to its inherent propensity for recurrence and varying susceptibility to available ...
Giacoppo, Daniele, Mazzone, Placido Maria, Capodanno, Davide   +2 more
openaire   +2 more sources

Degraded products generated by iron stent inhibit the vascular smooth muscle cell proliferation by downregulating AP-1

Journal of Materials Science: Materials in Medicine
In-stent restenosis (ISR) following interventional therapy is a fatal clinical complication. Current evidence indicates that neointimal hyperplasia driven by uncontrolled proliferation of vascular smooth muscle cells (VSMC) is a major cause of restenosis.
Jiabing Huang, Bingjian Liu, Chunguang Zhao, Jing Li, Dongxu Qiu   +4 more
doaj   +1 more source

In-Stent Restenosis [PDF]

Cardiovascular Therapeutics, 2010
Michael S. Kim, Larry S. Dean
openaire   +1 more source

Development of coronary stents using advanced results of materials science and technology [PDF]

, 2004
Stents are high tech endovascular implants. K&M Inc. is the single Eastern European stent producer company. The market needs more biocompatible devices as the trend of the stent development all the producers have to react.
Dobránszky, János, Major, L., Nyitrai, Zs., Puskás, Zs.   +3 more
core  

Percutaneous Ureteric Stricture Dilation (PCUSD) [PDF]

, 1997
Ureteric stricture dilation as an interventional uroradiological technique was initiated locally in March 1991. In ureteric dilation two approaches are feasible.
Cutajar, Lino, Formosa, Norman, Schranz, Martin, Wood, Corinne, Zammit, Anthony   +4 more
core  

Different properties of coronary stents [PDF]

, 2007
Stents are mesh structured implants which are used to support the vessel wall in the balloon expanded vessel part. Several methods were developed and applied for the determination of mechanical properties of coronary stents, as a part of a complex pre ...
Bognár, Eszter, Bálint-Pataki, Zsófia, Dobránszky, János, Ring, György   +3 more
core  

Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis [PDF]

, 2000
BACKGROUND: Treatment of in-stent restenosis presents a critical limitation of intracoronary stent implantation. Ionizing radiation has been shown to decrease neointimal formation within stents in animal models and in initial clinical ...
Bass, B.G. (Bill), Bhargava, B., Chan, R.C., Fitzgerald, P.J. (Peter), Geirlach, L., Kent, K.M. (Kenneth), Lansky, A.J. (Alexandra), Leon, M.B. (Martin), Mehran, R. (Roxana), Mintz, G.S. (Gary), Pichard, A.D., Satler, L.F., Serruys, P.W.J.C. (Patrick), Waksman, R. (Ron), White, L.R. (Larry)   +14 more
core